Our Portfolio

Fujirebio Europe NV

Manu Vandijck | Vlaanderen, Belgium

Project Overview

  • Biotechnology/For Profit Organization Type
  • $725,922 Funding Amount
  • 7/1/24 — 7/1/25 Project Duration
  • Diagnostics Accelerator Program
  • Blood Biomarker Type
  • Active Status

Fujirebio Europe NV

Manu Vandijck | Vlaanderen, Belgium

Plasma pTau217 detection with the LUMIPULSE G platform as indicator for Alzheimer’s Disease

GET IN TOUCH